Drug repurposing of ticagrelor suppresses renal cell carcinoma growth by blockading the EGFR/PI3K/AKT axis. [PDF]
Ann MedYang Y +6 more
europepmc +1 more source
Half-dose ticagrelor versus clopidogrel dual antiplatelet therapy in flow diverter-treated intracranial aneurysms: analysis of platelet reactivity and perioperative safety outcomes. [PDF]
Acta Neurochir (Wien)Li C +16 more
europepmc +1 more source
Risk of clopidogrel resistance in endovascular aneurysm stenting. [PDF]
Surg Neurol IntStanton M, Ng W, Jonathan A.
europepmc +1 more source
Safety profile of ticagrelor: an analysis based on literature and database review. [PDF]
BMC Cardiovasc DisordLiu R, Xiao L, Yan Q, Liu X.
europepmc +1 more source
Ticagrelor Resistance Causing Acute In-Stent Thrombosis: Successful Management With Prasugrel and Balloon Angioplasty. [PDF]
J Med CasesJia K +4 more
europepmc +1 more source
Influence of Chronic Kidney Disease on Platelet Reactivity Response to Clopidogrel and Ticagrelor. [PDF]
Int J Mol SciFranci A +10 more
europepmc +1 more source
Overcoming Clopidogrel Resistance in Carotid Artery Stenting: Experience with Ticagrelor and Ticlopidine. [PDF]
Clin PractVigláš P +6 more
europepmc +1 more source
Comparison of clinical efficacy and bleeding risk between ticagrelor and clopidogrel in elderly patients after percutaneous coronary intervention: A retrospective study. [PDF]
Medicine (Baltimore)Luo J, Liang G, Chen A.
europepmc +1 more source
Safety and Efficacy Comparison of Ticagrelor versus Other P2Y12 Inhibitors in Combination with Oral Anticoagulants as a Part of DAPT/SAPT in Patients with Concomitant Atrial Fibrillation and Coronary Artery Disease: A Meta-Analysis. [PDF]
Ther Clin Risk ManagLi Y, Gong J, Liu N.
europepmc +1 more source